ArticleBiomedicines2025

CHIVAX 2.1-Loaded Chitosan Nanoparticles as Intranasal Vaccine Candidates for COVID-19: Development and Murine Safety Assessment.

Lineth Juliana Vega-Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.